Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Lifespan brain activity, β-amyloid, and Alzheimer's disease.

Jagust WJ, Mormino EC.

Trends Cogn Sci. 2011 Nov;15(11):520-6. doi: 10.1016/j.tics.2011.09.004. Epub 2011 Oct 7.

PMID:
21983147
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.

Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003. Review.

PMID:
22531423
[PubMed - indexed for MEDLINE]
3.

Amyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive decline.

Reddy PH, Manczak M, Mao P, Calkins MJ, Reddy AP, Shirendeb U.

J Alzheimers Dis. 2010;20 Suppl 2:S499-512. doi: 10.3233/JAD-2010-100504. Review.

PMID:
20413847
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
[PubMed - indexed for MEDLINE]
5.

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.

Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2010 Nov;133(11):3336-48. doi: 10.1093/brain/awq277. Epub 2010 Oct 8.

PMID:
20935035
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
[PubMed - indexed for MEDLINE]
7.

Alzheimer disease: Aβ-independent processes-rethinking preclinical AD.

Chételat G.

Nat Rev Neurol. 2013 Mar;9(3):123-4. doi: 10.1038/nrneurol.2013.21. Epub 2013 Feb 12.

PMID:
23399647
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Bignante EA, Heredia F, Morfini G, Lorenzo A.

Neurobiol Aging. 2013 Nov;34(11):2525-37. doi: 10.1016/j.neurobiolaging.2013.04.021. Epub 2013 May 25. Review.

PMID:
23714735
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

PMID:
22191795
[PubMed - indexed for MEDLINE]
10.

Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.

Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.

J Alzheimers Dis. 2010;20 Suppl 2:S535-50. doi: 10.3233/JAD-2010-100342.

PMID:
20463404
[PubMed - indexed for MEDLINE]
11.

L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.

Peng Y, Sun J, Hon S, Nylander AN, Xia W, Feng Y, Wang X, Lemere CA.

J Neurosci. 2010 Jun 16;30(24):8180-9. doi: 10.1523/JNEUROSCI.0340-10.2010.

PMID:
20554868
[PubMed - indexed for MEDLINE]
Free Article
12.

Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.

Okada H, Ouchi Y, Ogawa M, Futatsubashi M, Saito Y, Yoshikawa E, Terada T, Oboshi Y, Tsukada H, Ueki T, Watanabe M, Yamashita T, Magata Y.

Brain. 2013 Oct;136(Pt 10):3004-17. doi: 10.1093/brain/awt195. Epub 2013 Aug 24.

PMID:
23975517
[PubMed - indexed for MEDLINE]
Free Article
13.

Beta-amyloid deposition and the aging brain.

Rodrigue KM, Kennedy KM, Park DC.

Neuropsychol Rev. 2009 Dec;19(4):436-50. doi: 10.1007/s11065-009-9118-x. Epub 2009 Nov 12. Review.

PMID:
19908146
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?

Struble RG, Ala T, Patrylo PR, Brewer GJ, Yan XX.

J Alzheimers Dis. 2010;22(2):393-9. doi: 10.3233/JAD-2010-100846. Review.

PMID:
20847431
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Sultana R, Perluigi M, Butterfield DA.

Acta Neuropathol. 2009 Jul;118(1):131-50. doi: 10.1007/s00401-009-0517-0. Epub 2009 Mar 14. Review.

PMID:
19288120
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.

Hoshino T, Murao N, Namba T, Takehara M, Adachi H, Katsuno M, Sobue G, Matsushima T, Suzuki T, Mizushima T.

J Neurosci. 2011 Apr 6;31(14):5225-34. doi: 10.1523/JNEUROSCI.5478-10.2011.

PMID:
21471357
[PubMed - indexed for MEDLINE]
Free Article
17.

Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.

Tosun D, Schuff N, Mathis CA, Jagust W, Weiner MW; Alzheimer's Disease NeuroImaging Initiative.

Brain. 2011 Apr;134(Pt 4):1077-88. doi: 10.1093/brain/awr044. Epub 2011 Mar 22.

PMID:
21429865
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.

Cao C, Cirrito JR, Lin X, Wang L, Verges DK, Dickson A, Mamcarz M, Zhang C, Mori T, Arendash GW, Holtzman DM, Potter H.

J Alzheimers Dis. 2009;17(3):681-97. doi: 10.3233/JAD-2009-1071. Erratum in: J Alzheimers Dis. 2009 Nov;18(3):727. Wang, Lilly [corrected to Wang, Li]..

PMID:
19581723
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease.

Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E.

Acta Neuropathol. 2010 May;119(5):523-41. doi: 10.1007/s00401-010-0679-9. Epub 2010 Mar 31. Review.

PMID:
20354705
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.

Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group.

Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9.

PMID:
21310725
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk